Few studies explored the role of the IL33/ST2 pathway in the context of heart valve disease, suggesting that it could be involved in the pathogenesis of aortic and mitral valve disease; however, the high levels of sST2 observed in heart valve disease could also be related to heart failure symptoms developed by these patients. This evidence concerns the gene IL33 and heart failure.